A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis

Summary

This study will evaluate the efficacy, safety, and pharmacokinetics of BFKB8488A compared to placebo in participants with non-alcoholic steatohepatitis (NASH).

Timeline

Start

2020-09-30

Primary completion

2023-01-23

Completion

2023-01-23

Outcome

Outcome not reported

Stopped (Business): “The study was terminated due to strategic business reasons.”

Drugs

Indications